Literature DB >> 16387007

A novel RPGR exon ORF15 mutation in a family with X-linked retinitis pigmentosa and Coats'-like exudative vasculopathy.

F Yesim K Demirci1, Brian W Rigatti, Tammy S Mah, Michael B Gorin.   

Abstract

PURPOSE: To describe the ophthalmic and genetic findings in a family with X-linked retinitis pigmentosa (RP) and Coats'-like exudative vasculopathy.
DESIGN: Observational case series.
METHODS: Family members underwent comprehensive ophthalmologic examination. Leukocyte genomic DNA samples were obtained and screened for RPGR (RP3) mutations by direct polymerase chain reaction sequencing.
RESULTS: The proband had RP with bilateral Coats'-like vasculopathy and was treated with fluorescein-potentiated argon laser therapy. The findings in two other affected male patients and three obligate carrier female patients were within the clinical spectrum of a typical X-linked-recessive RP. A novel nonsense RPGR exon ORF15 mutation (912G>T) was found to segregate with RP in this family.
CONCLUSIONS: This report expands the clinical heterogeneity spectrum caused by RPGR mutations and our knowledge concerning the molecular pathologic condition that pertains to Coats'-like RP. Consistent with the literature, Coats' response was not observed in all family members who were affected by RP, which suggests the involvement of other genetic and/or environmental factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16387007     DOI: 10.1016/j.ajo.2005.07.077

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

Review 1.  Multiprotein complexes of Retinitis Pigmentosa GTPase regulator (RPGR), a ciliary protein mutated in X-linked Retinitis Pigmentosa (XLRP).

Authors:  Carlos Murga-Zamalloa; Anand Swaroop; Hemant Khanna
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.

Authors:  Omar Moinuddin; Sanjana Sathrasala; K Thiran Jayasundera; Kari H Branham; Emmanuel Y Chang; Cynthia X Qian; Franco M Recchia; Abigail T Fahim; Cagri G Besirli
Journal:  Ophthalmol Retina       Date:  2020-04-09

3.  A Case of Retinitis Pigmentosa Requiring Vitrectomy because of Repeated Vitreous Hemorrhage.

Authors:  Akira Watanabe; Goichi Akiyama; Hiroshi Tsuneoka
Journal:  Case Rep Ophthalmol       Date:  2011-08-18

4.  X-linked dominant RPGR gene mutation in a familial Coats angiomatosis.

Authors:  Antonio Pizzuti; Enrica Marchionni; Marcella Nebbioso; Federica Franzone; Alessandro Lambiase; Maurizio La Cava; Fabiana Mallone
Journal:  BMC Ophthalmol       Date:  2021-01-14       Impact factor: 2.209

5.  Multimodal treatment of Coats-like exudative vitreoretinopathy in Goldmann-Favre syndrome.

Authors:  Fabiola Ramos Nieves; Victor M Villegas; Nimesh A Patel; Audina M Berrocal; Timothy G Murray
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-29

6.  Genotype-Phenotype Analysis of RPGR Variations: Reporting of 62 Chinese Families and a Literature Review.

Authors:  Junxing Yang; Lin Zhou; Jiamin Ouyang; Xueshan Xiao; Wenmin Sun; Shiqiang Li; Qingjiong Zhang
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

7.  Peripheral Inflammatory Yellow Exudative Retinal Coats-Like Vitreoretinopathy Misdiagnosed as Acute Retinal Necrosis in a Retinitis Pigmentosa Patient after Cataract Surgery.

Authors:  Lara Tran; Ioannis Papasavvas; Johannes Fleischhauer; Carl P Herbort
Journal:  Case Rep Ophthalmol       Date:  2021-06-18

8.  A novel missense variant c.G644A (p.G215E) of the RPGR gene in a Chinese family causes X-linked retinitis pigmentosa.

Authors:  Jiewen Fu; Jingliang Cheng; Qi Zhou; Chunli Wei; Hanchun Chen; Hongbin Lv; Junjiang Fu
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

Review 9.  Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.

Authors:  Mays Talib; Camiel J F Boon
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.